Mirati Therapeutics
MRTX
#3041
Rank
ยฃ3.25 B
Marketcap
ยฃ46.34
Share price
0.00%
Change (1 day)
46.06%
Change (1 year)

Mirati Therapeutics (MRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2023 : ยฃ0.14 Billion

According to Mirati Therapeutics's latest financial reports the company's total liabilities are ยฃ0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Mirati Therapeutics - Total liabilities on balance sheet (from 2005 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31ยฃ0.17 B19.96%
2021-12-31ยฃ0.14 B67.85%
2020-12-31ยฃ84.61 M122.34%
2019-12-31ยฃ38.05 M79.73%
2018-12-31ยฃ21.17 M105.03%
2017-12-31ยฃ10.32 M-15.8%
2016-12-31ยฃ12.26 M84.71%
2015-12-31ยฃ6.64 M90.86%
2014-12-31ยฃ3.47 M-85.15%
2013-12-31ยฃ23.43 M603.32%
2012-12-31ยฃ3.33 M37.69%
2011-12-31ยฃ2.41 M-45.47%
2010-12-31ยฃ4.43 M-20.86%
2009-12-31ยฃ5.6 M-24.19%
2008-12-31ยฃ7.39 M-47.84%
2007-12-31ยฃ14.17 M13.04%
2006-12-31ยฃ12.54 M262.36%
2005-12-31ยฃ3.46 M14.29%
2004-12-31ยฃ3.02 M-33.12%
2003-12-31ยฃ4.52 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ2.13 B 1,378.20%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.48 M-98.28% Bahamas